Microbial markers in colorectal cancer detection and/or prognosis
- PMID: 29904241
- PMCID: PMC6000297
- DOI: 10.3748/wjg.v24.i22.2327
Microbial markers in colorectal cancer detection and/or prognosis
Abstract
Colorectal cancer (CRC) is the second leading cause of cancer worldwide. CRC is still associated with a poor prognosis among patients with advanced disease. On the contrary, due to its slow progression from detectable precancerous lesions, the prognosis for patients with early stages of CRC is encouraging. While most robust methods are invasive and costly, actual patient-friendly screening methods for CRC suffer of lack of sensitivity and specificity. Therefore, the development of sensitive, non-invasive and cost-effective methods for CRC detection and prognosis are necessary for increasing the chances of a cure. Beyond its beneficial functions for the host, increasing evidence suggests that the intestinal microbiota is a key factor associated with carcinogenesis. Many clinical studies have reported a disruption in the gut microbiota balance and an alteration in the faecal metabolome of CRC patients, suggesting the potential use of a microbial-based test as a non-invasive diagnostic and/or prognostic tool for CRC screening. This review aims to discuss the microbial signatures associated with CRC known to date, including dysbiosis and faecal metabolome alterations, and the potential use of microbial variation markers for non-invasive early diagnosis and/or prognostic assessment of CRC and advanced adenomas. We will finally discuss the possible use of these markers as predicators for treatment response and their limitations.
Keywords: Colibactin-producing E. coli; Colorectal cancer; Diagnostic markers; Dysbiosis; F. nucleatum; Microbiota; Prognostic markers.
Conflict of interest statement
Conflict-of-interest statement: None of the authors have any conflicts of interest to declare.
Figures


Similar articles
-
Faecal microbial biomarkers in early diagnosis of colorectal cancer.J Cell Mol Med. 2021 Dec;25(23):10783-10797. doi: 10.1111/jcmm.17010. Epub 2021 Nov 9. J Cell Mol Med. 2021. PMID: 34750964 Free PMC article. Review.
-
Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.J Adv Res. 2023 Oct;52:45-57. doi: 10.1016/j.jare.2022.12.015. Epub 2022 Dec 31. J Adv Res. 2023. PMID: 36596411 Free PMC article. Review.
-
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.J Gastroenterol Hepatol. 2020 Dec;35(12):2109-2121. doi: 10.1111/jgh.15077. Epub 2020 Jun 22. J Gastroenterol Hepatol. 2020. PMID: 32337748
-
Microbiome and fragmentation pattern of blood cell-free DNA and fecal metagenome enhance colorectal cancer micro-dysbiosis and diagnosis analysis: a proof-of-concept study.mSystems. 2025 May 20;10(5):e0027625. doi: 10.1128/msystems.00276-25. Epub 2025 Apr 29. mSystems. 2025. PMID: 40298367 Free PMC article.
-
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19. mBio. 2020. PMID: 32071266 Free PMC article.
Cited by
-
Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population.PLoS One. 2022 Nov 11;17(11):e0262662. doi: 10.1371/journal.pone.0262662. eCollection 2022. PLoS One. 2022. PMID: 36367873 Free PMC article.
-
The Role of Gut Microbiome Perturbation in Fatigue Induced by Repeated Stress from Chemoradiotherapy: A Proof of Concept Study.Adv Med. 2020 Feb 7;2020:6375876. doi: 10.1155/2020/6375876. eCollection 2020. Adv Med. 2020. PMID: 32090133 Free PMC article.
-
Deciphering microbial and metabolic influences in gastrointestinal diseases-unveiling their roles in gastric cancer, colorectal cancer, and inflammatory bowel disease.J Transl Med. 2025 May 16;23(1):549. doi: 10.1186/s12967-025-06552-w. J Transl Med. 2025. PMID: 40380167 Free PMC article.
-
Intratumoral microbial community profiling identifies clinicomolecular and prognostic subtypes of colorectal cancer liver metastasis.NPJ Precis Oncol. 2025 Aug 15;9(1):284. doi: 10.1038/s41698-025-01075-5. NPJ Precis Oncol. 2025. PMID: 40813885 Free PMC article.
-
Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review.Front Oncol. 2024 Jul 26;14:1405267. doi: 10.3389/fonc.2024.1405267. eCollection 2024. Front Oncol. 2024. PMID: 39132504 Free PMC article.
References
-
- Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117. - PubMed
-
- Rees CJ, Bevan R. The National Health Service Bowel Cancer Screening Program: the early years. Expert Rev Gastroenterol Hepatol. 2013;7:421–437. - PubMed
-
- Jones RP, Jackson R, Dunne DF, Malik HZ, Fenwick SW, Poston GJ, Ghaneh P. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg. 2012;99:477–486. - PubMed
-
- O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–1425. - PubMed
-
- Winawer SJ. The history of colorectal cancer screening: a personal perspective. Dig Dis Sci. 2015;60:596–608. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases